Valion Bio annual operating margin
2021
2022
2023
2024
Valion Bio's operating margin was −573.85% for fiscal 2024.
View full Valion Bio company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −573.85% | +127.26 pp |
| 2023 | 2023-12-31 | −701.11% | −152.30 pp |
| 2022 | 2022-12-31 | −548.80% | −100.67 pp |
| 2021 | 2021-12-31 | −448.13% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −1,700.68% | −564.97 pp |
| Q2 2025 | 2025-06-30 | −1,951.16% | −1046.88 pp |
| Q1 2025 | 2025-03-31 | −1,967.14% | −1523.73 pp |
| Q4 2024 | 2024-12-31 | −165.56% | +463.02 pp |
| Q3 2024 | 2024-09-30 | −1,135.71% | −511.60 pp |
| Q2 2024 | 2024-06-30 | −904.29% | +415.59 pp |
| Q1 2024 | 2024-03-31 | −443.41% | +119.35 pp |
| Q4 2023 | 2023-12-31 | −628.57% | −74.52 pp |
| Q3 2023 | 2023-09-30 | −624.11% | −82.39 pp |
| Q2 2023 | 2023-06-30 | −1,319.88% | −748.28 pp |
| Q1 2023 | 2023-03-31 | −562.77% | −39.17 pp |
| Q4 2022 | 2022-12-31 | −554.05% | +35.15 pp |
| Q3 2022 | 2022-09-30 | −541.72% | −98.04 pp |
| Q2 2022 | 2022-06-30 | −571.59% | −177.93 pp |
| Q1 2022 | 2022-03-31 | −523.60% | −196.35 pp |
| Q4 2021 | 2021-12-31 | −589.20% | — |
| Q3 2021 | 2021-09-30 | −443.68% | — |
| Q2 2021 | 2021-06-30 | −393.66% | — |
| Q1 2021 | 2021-03-31 | −327.24% | — |
Across the available reported history, Valion Bio's operating margin increased from −701.11% to −573.85%, a change of +127.26 percentage points. The latest reported quarter, Q3 2025, shows −1,700.68%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Valion Bio filings at SEC.gov ↗